… correlates of depression non-remission and antidepressant augmentation treatment use …
non-remission and medication augmentation treatment in individuals receiving antidepressant …

… attain remissionCitation 6 . … between patients who augment versus switch therapy are
unknown. The choice to receive treatment augmentation versus switching to a new antidepressant …

… incidence of remission. Among patients in whom augmentation or a switch to bupropion …
remission with lithium augmentation or a switch to nortriptyline were similar. (Funded by the …

… to a different treatment rather than augmenting their initial … /remission occur in those who
will respond or remit?” or “Can we identify early the patients for whom a second-step switch …

… and augmentation drugs, after they exhibited remission … the effect of discontinuing ketamine
used as an augmentation … Moreover, this study included an antidepressant switch when …

… For patients who have intolerable side effects or who do not … and include switching
antidepressants or augmenting them … no difference in remission between treatment groups (Figure …

… agents, response rates to initial antidepressant monotherapy hover at 60%, and remissions
… On the whole, in our analysis, treatment effects of antidepressant combinations were not …

… : switch the index antidepressant to bupropion SR (S-BUP), combine the index … in remission
at Week 12, there were no significant differences in cumulative emergent remission between …

… for randomisation involved either switching to a new treatment or augmenting the patient’s …
Cognitive therapy was also available as either a switch or citalopram augmentation option …

… , remission rates after an initial 8~12 week antidepressant … to be less than one third in patients
with MDD (Keller et al., May … antidepressants over the 4 steps; vii) switch + augmentation + …